Close Menu
    Latest Category
    • Finance
    • Tech
    • EU Law
    • Energy
    • About
    • Contact
    EUbusiness.com | EU news, business and politicsEUbusiness.com | EU news, business and politics
    Login
    • EU News
    • Focus
    • Guides
    • Press
    • Jobs
    • Events
    • Directory
    EUbusiness.com | EU news, business and politicsEUbusiness.com | EU news, business and politics
    Home » EU probes Aspen price hikes for cancer drugs

    EU probes Aspen price hikes for cancer drugs

    npsBy nps17 May 2017Updated:25 June 2024 No Comments2 Mins Read
    — Filed under: EU News Health Pharmaceuticals
    Share
    Facebook Twitter LinkedIn Pinterest Email
    EU probes Aspen price hikes for cancer drugs

    Drugs

    (BRUSSELS) – The European Commission opened Monday a formal investigation into concerns that Aspen Pharma has engaged in excessive pricing concerning five life-saving cancer medicines.

    The investigation concerns the pricing practices of Southg-Agrican based Aspen for niche medicines containing the active pharmaceutical ingredients chlorambucil, melphalan, mercaptopurine, tioguanine and busulfan.

    The medicines in question are used for treating cancer, such as hematologic tumours. They are sold with different formulations and under multiple brand names. Aspen acquired these medicines after their patent protection had expired.

    The Commission says it will investigate information indicating that Aspen has imposed very significant and unjustified price increases of up to several hundred percent, so-called ‘price gouging’. The Commission has information that, for example, to impose such price increases, Aspen has threatened to withdraw the medicines in question in some Member States and has actually done so in certain cases.

    “Companies should be rewarded for producing these pharmaceuticals to ensure that they keep making them into the future,” said Competition Commissioner Margrethe Vestager. “But when the price of a drug suddenly goes up by several hundred per cent, this is something the Commission may look at.”

    The EU executive says Aspen’s behaviour may be in breach of the EU’s antitrust rules (Article 102 of the Treaty on the Functioning of the European Union (TFEU) and Article 54 of the European Economic Area (EEA) Agreement, which forbid the imposition of unfair prices or unfair trading conditions on customers.

    The investigation covers all of the EEA except Italy, where the Italian competition authority already adopted an infringement decision against Aspen on 29 September 2016.

    This is the Commission’s first investigation into concerns about excessive pricing practices in the pharmaceutical industry.

    More information on the investigation will be available on the Commission’s competition website, in the public case register under the case number 40394.

    Add A Comment
    Leave A Reply Cancel Reply

    You must be logged in to post a comment.

    nps
    • Website

    Related Content

    Sustainable finance - Image by Nattanan Kanchanaprat from Pixabay

    Brussels eases corporate sustainability reporting requirements

    Tochytskyi - Micallef - Ukraine Recovery Conference - Photo © European Union 2025

    EU offers support for Ukraine culture and heritage

    Euro - ECB-Photo by Mika Baumeister on Unsplash

    Poor GDP performance marks end of tough week for the Pound – Euro currency news daily

    Ukraine Recovery Conference - Photo © European Union 2025

    EU announces EUR 2.3 billion package for Ukraine recovery

    Ecommerce - Photo by AS Photography on Pexels

    Euro-Parliament moves to stop sub-standard products from outside EU

    Deforestation - Image by Robert Jones from Pixabay

    EUDR saga: Parliament votes to undermine enforcement and EU credibility

    Sponsor: WWF European Policy Office9 July 2025
    LATEST EU NEWS
    Sustainable finance - Image by Nattanan Kanchanaprat from Pixabay

    Brussels eases corporate sustainability reporting requirements

    11 July 2025
    Tochytskyi - Micallef - Ukraine Recovery Conference - Photo © European Union 2025

    EU offers support for Ukraine culture and heritage

    11 July 2025
    Euro - ECB-Photo by Mika Baumeister on Unsplash

    Poor GDP performance marks end of tough week for the Pound – Euro currency news daily

    11 July 2025
    Ukraine Recovery Conference - Photo © European Union 2025

    EU announces EUR 2.3 billion package for Ukraine recovery

    10 July 2025
    Ecommerce - Photo by AS Photography on Pexels

    Euro-Parliament moves to stop sub-standard products from outside EU

    10 July 2025

    Subscribe to EUbusiness Week

    Get the latest EU news

    CONTACT INFO

    • EUbusiness Ltd 117 High Street, Chesham Buckinghamshire, HP5 1DE United Kingdom
    • +44(0)20 8058 8232
    • service@eubusiness.com

    INFORMATION

    • About Us
    • Advertising
    • Contact Info

    Services

    • Privacy Policy
    • Terms
    • EU News

    SOCIAL MEDIA

    Facebook
    eubusiness.com © EUbusiness Ltd 2025

    Design and developed by : 

    Type above and press Enter to search. Press Esc to cancel.

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?